GlassScriptPhysician profile
Alexander Behnaz
NPI 1902398449
$17,594.78
in general payments reported to CMS, 2019-2025
40 companies · $4,109 in 2025
The $4,109 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.54 · 2022: $1,724 · 2023: $3,441 · 2024: $8,260 · 2025: $4,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $2,186 · Education: $19.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,604.20 |
| Travel and Lodging | $2,186.37 |
| Education | $19.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,792.32 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $3,068.13 | 2022-2025 | Proclaim, Eterna, Octrode |
| Curonix LLC | $1,576.16 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $1,158.73 | 2023-2025 | Reactiv8 |
| Boston Scientific Corporation | $888.66 | 2022-2025 | Infinion 16, Wavewriter Alpha Prime 16, General - Pain Management |
| Vertos Medical, INC. | $693.76 | 2023-2024 | Mild Device Kit |
| Abbvie INC. | $322.87 | 2025 | |
| Neurocrine Biosciences, INC. | $190.18 | 2025 | |
| Axogen | $148.89 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $145.29 | 2023-2024 | Exparel, Iovera, Zilretta |
| Axsome Therapeutics, INC. | $141.64 | 2025 | Symbravo |
| Amneal Pharmaceuticals LLC | $111.85 | 2025 | Crexont |
| Lundbeck LLC | $111.79 | 2022-2025 | Vyepti |
| Emd Serono, INC. | $103.99 | 2025 | Mavenclad |
| Biogen, INC. | $100.22 | 2025 | Leqembi |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $100.04 | 2023 | Intracept |
| Impel Pharmaceuticals INC. | $89.54 | 2022 | |
| Lilly USA, LLC | $87.79 | 2025 | Kisunla, Amyvid, Zepbound |
| Nevro Corp. | $84.49 | 2023 | Senza |
| Bioventus LLC | $83.33 | 2025 | Stimrouter Implantable Kit |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
| Allergan, INC. | $78.87 | 2021-2022 | |
| Tersera Therapeutics LLC | $66.26 | 2024-2025 | Prialt |
| Eisai INC. | $40.11 | 2025 | |
| Csl Behring | $28.74 | 2025 | Hizentra |
| Pfizer INC. | $27.30 | 2025 | |
| Neurelis, INC. | $25.87 | 2025 | Valtoco |
| Vanda Pharmaceuticals INC. | $24.92 | 2025 | Ponvory |
| Electronic Waveform Lab, INC. | $22.49 | 2025 | |
| Painteq LLC | $22.38 | 2024 | Painteq |
| Teva Pharmaceuticals USA, INC. | $21.94 | 2025 | Austedo Xr |
| Ucb, INC. | $21.56 | 2025 | Nayzilam |
| Depuy Synthes Sales INC. | $19.87 | 2024 | Orthovisc |
| Ipsen Biopharmaceuticals, INC | $19.43 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.17 | 2025 | Hyqvia |
| Astrazeneca Pharmaceuticals LP | $16.46 | 2025 | Wainua |
| Paratek Pharmaceuticals, INC. | $16.10 | 2024 | Nuzyra |
| Janssen Biotech, INC. | $15.50 | 2025 | |
| Convatec INC. | $15.40 | 2024 | |
| Smith+Nephew, INC. | $13.93 | 2024 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Behnaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.